Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The SOX2 promoter G-quadruplex (SOX2-G4) is a non-canonical DNA secondary structure located within the regulatory region of the SRY-box transcription factor 2 (SOX2) gene. This specific structure belongs to the Pu27 family of G-quadruplexes, which are characterized by high sequence homology to the well-studied Pu27 silencer element in the c-MYC promoter (1.2.1, 1.3.1). In its folded state, the SOX2-G4 acts as a transcriptional repressor, and its stabilization by small molecules or specific ligands leads to the downregulation of SOX2 expression (1.4.2). SOX2 is a master regulator of pluripotency and self-renewal in both embryonic stem cells and cancer stem cells (CSCs), making this G-quadruplex an attractive therapeutic target for various malignancies, including glioblastoma, breast cancer, and leukemia (1.1.2, 1.4.5). Targeting the SOX2-G4 with ligands such as triplex metallohelices or Pu27-homologous oligonucleotides has been shown to reduce tumor initiation and viability by depleting the CSC population (1.4.2, 1.3.5). However, therapeutic challenges include achieving selectivity over other genomic G-quadruplexes and avoiding toxicity in normal stem cell niches where SOX2 function is essential (1.5.3, 1.5.4).
Stabilization of the G-quadruplex structure within the SOX2 promoter leads to transcriptional repression of the SOX2 gene, thereby inhibiting the maintenance and proliferation of cancer stem cells.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SOX2 promoter G-quadruplex (SOX2-G4).